Lexicon Pharmaceuticals | Capitalização De Mercado





Capitalização De Mercado Alterar Data
Abbott USD 217.86B 15.25B 2025-12
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Akebia Therapeutics USD 502M 75M 2025-03
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Coherus Biosciences USD 94M 65M 2025-03
Eli Lilly USD 1.02T 293.84B 2025-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
Illumina USD 20.62B 6.53B 2025-12
Insmed USD 37.12B 6.68B 2025-12
J&J USD 500.24B 67.44B 2025-12
MacroGenics USD 106M 29M 2025-09
MannKind USD 1.74B 93M 2025-12
Merck USD 261.26B 51.62B 2025-12
Novartis USD 265.66B 9.48B 2025-09
PTC Therapeutics USD 6.1B 1.22B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Thermo Fisher Scientific USD 217.7B 42.4B 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Vanda Pharmaceuticals USD 279M 6M 2024-12


Lexicon Pharmaceuticals Capitalização De Mercado - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2026.